CRISPR Therapeutics AG may be overvalued with poor growth indicators, but the 26 analysts following the company give it an average rating of buy. The analysts have set target prices ranging from $42.0 to $220.0 per share, for an average of $83.54. At today's price of $61.71, CRISPR Therapeutics AG is trading -26.13% away from its average target price, suggesting there is an analyst consensus of strong upside potential.
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Based in Zug, Switzerland, the mid-cap Health Care company has 458 full time employees. CRISPR Therapeutics AG has not offered a regular dividend during the last year.
CRISPR Therapeutics AG does not have a meaningful trailing P/E ratio since its earnings per share are negative. Its forward EPS guidance is negative too, at -6.59. The average P/E ratio for the Health Care sector is 24.45. On the other hand, the market is undervaluing CRISPR Therapeutics AG in terms of its net assets because its P/B ratio is 2.62. In comparison, the sector average is 4.16.
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Revenue (k) | $289,590 | $543 | $913,081 | $436 |
| Gross Margins | n/a | n/a | n/a | -25186.7% |
| Operating Margins | 16.1% | -65273.5% | 40.9% | -154394.7% |
| Net Margins | 23.09% | -64247.7% | 41.36% | -149122.71% |
| Net Income (k) | $66,858 | -$348,865 | $377,661 | -$650,175 |
| Depreciation & Amort. | -$4,725 | -$9,184 | -$17,953 | -$24,172 |
| Earnings Per Share | $1.17 | -$5.29 | $4.7 | -$6.68 |
| EPS Growth | n/a | -552.14% | 188.85% | -242.13% |
| Diluted Shares (k) | 56,933 | 65,950 | 80,393 | 78,935 |
| Free Cash Flow (k) | $49,993 | -$256,724 | $457,267 | -$532,929 |
| Capital Expenditures | -$6,684 | -$18,358 | -$81,705 | -$37,188 |
| Net Current Assets (k) | $860,220 | $1,552,888 | $2,065,096 | $1,485,448 |
| Current Ratio | 17.29 | 18.21 | 20.17 | 15.3 |
